Japanese
English
Home
About Us
Message from CEO
Our Mission
Our Business
Corporate Information
Leadership/ Governance
Access
Our Science
PRIME Technology
Application of Our Technology
Pipelines
Our Partners
IR
IR News
Management
Top Message
Corporate Governance
Disclosure Policy
Financial Highlights
IR Library
Financial Results
Presentation Materials
Securities Report
IR Materials
Stock Information
Stock Overview
General Meeting of Shareholders
Stock Quotations
IR Calendar
IR FAQ
IR Contact
Disclaimer
Careers
Contact Us
Contact Us
Create the Future to Overcome Cancer
News
2024/03/28
Announcement regarding the Appointment of New Outside Director
2024/03/22
Presentation at the 23rd Congress of the Japanese Society for Regenerative Medicine Challenge for Manufacturing Gene-modified T cells using an Automated Culture System (updated content 2024/03/27)
2023/12/18
[Delayed]Supplemental Comments on the Termination of the License Agreements for NIB102 and NIB103
2023/12/16
Announcement on the Termination of License Agreement for NIB102 and NIB103
2023/12/06
Our President & CEO, Koji Tamada, made an appearance on Radio NIKKEI “この企業に注目！相場の福の神” on December 1, 2023 (Friday).
Details
